Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're searching for the cheapest place for 7.5mg Mounjaro, the honest answer is that UK private prices vary by dose and provider, and the headline figure rarely tells the whole story. Mounjaro is a prescription-only medicine; every legitimate supply must follow a clinical assessment by a qualified prescriber. The 7.5mg dose sits mid-way up the licensed titration schedule, which means most people reaching it have already been on treatment for several weeks — and the price at this dose is higher than the 2.5mg or 5mg starting pens. Since Eli Lilly raised its UK list prices from 1 September 2025, private providers have typically charged somewhere between £149 and £375 per four-week pen depending on dose and service, as widely reported at the time. Any price below that range from an unverified seller is a red flag worth taking seriously. You can explore the full Mounjaro price context separately if you'd like the broader picture across all doses.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's easy to assume that Mounjaro is Mounjaro regardless of where you buy it, a licensed pen is a licensed pen, so why not find the cheapest listing? That assumption ignores what legitimate supply actually involves. A GPhC-registered pharmacy sourcing tirzepatide through the authorised UK supply chain has fixed wholesale costs it cannot discount away. When a price looks dramatically lower than the market range, something has been removed from the equation: often the prescriber review, the aftercare, or in the worst cases the medicine's provenance itself.
The MHRA raided the UK's first illicit manufacturing site producing counterfeit tirzepatide pens in Northampton in October 2025, following earlier seizures of approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million. Fake pens have contained insulin and other substances. The regulator's Yellow Card reporting site is where suspected counterfeit sellers can be reported, and worth bookmarking. Searching for the cheapest price is understandable; buying from an unverified source to get there is a different risk entirely.
You can verify any online pharmacy on the GPhC register in about thirty seconds. If a seller is not listed there, they cannot legally supply prescription medicines in the UK. That check costs nothing and takes less time than most online baskets.
Private Mounjaro pricing is not standardised. Some providers quote a pen price and add consultation fees, prescription charges, and delivery on top. Others bundle some of those in. At 7.5mg specifically, the Lilly list-price increase from September 2025 pushed costs higher than the lower doses, so the gap between providers became more noticeable at this point in the titration schedule.
Before comparing prices, it's worth asking what each quote actually covers. Does it include a prescriber review, or just a questionnaire that goes to an algorithm? Is delivery charged separately? Is there someone to contact if you have a reaction after your first injection at this dose? These are not small details. A person stepping up to 7.5mg is at a dose where GI side effects can still be present; clinical support at that moment has real value. NICE's appraisal of tirzepatide (TA1026) recommends it be used alongside appropriate clinical support, not as a mail-order product with no follow-up.
The broader question of what drives Mounjaro pricing across doses is worth reading if you're still in the early stages of treatment.
We're not the cheapest option. That's a deliberate choice, not an oversight. Our single transparent price covers the clinical consultation, the prescription, the medicine itself, next-working-day DPD delivery, and seven-day aftercare, nothing added at checkout. A named clinician reads your consultation the same day; the same happens before every repeat. There are no subscriptions, no auto-renewals, and no surprise fees when you reach 7.5mg after titrating through earlier doses.
For a prescription medicine with a genuine titration schedule and real clinical decisions at each step, price is the wrong comparison point. The right questions are whether the pharmacy is GPhC-registered, whether a qualified prescriber is making the clinical call, and whether someone will pick up when you need them. You can read more about how nume works or meet our clinical team if you'd like to understand who's behind the service. Treatment options and current pricing are shown on our weight-loss treatments page, the one place on the site where we list what treatment costs, without the guesswork.
If you're comparing the 7.5mg dose with neighbouring steps in the schedule, we've put together a guide covering what to look for when buying Mounjaro 7.5mg and a separate breakdown of where to find the most competitive 7.5mg pricing without compromising on verified supply. The 5mg price context page covers what changes at that tier, and we've also covered the 2.5mg starter dose for anyone at the beginning of treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.